1 The bronchoconstrictor responses to 5-hydroxytryptamine (5-HT) were studied in the guinea-pig to establish whether they are partly attributable to parasympathetic activation within the airways. 5-HT dose-response curves were constructed in anaesthetized and ventilated guinea-pigs pretreated with saline, or by bilateral cervical vagotomy or vagotomy plus atropine 3 mg kg 1, i.v. Vagotomy had no effect on 5-HT-induced bronchoconstriction but vagotomy plus atropine significantly reduced it. 2 To determine whether parasympathetic activation within the airways resulted from pre-or postganglionic stimulation, 5-HT dose-response curves were constructed for two groups of vagotomized guineapigs treated with hexamethonium 2mgkg-1, or hexamethonium 2mgkg-', plus atropine 3mgkg-1. Guinea-pigs treated with hexamethonium plus atropine experienced significantly less 5-HT-induced bronchoconstriction than those treated with hexamethonium alone. 
Introduction 5-Hydroxytryptamine (5-HT) is a bronchoconstrictor agent which has been widely used to study bronchial reactivity in several species. 5-HT-induced bronchoconstriction is attributed to the direct action of 5-HT on airway smooth muscle and to a central vagal reflex resulting from the stimulation of irritant receptors in the airways. Parasympathetic nerve activation within the airways may also contribute to the bronchoconstrictor effects of 5-HT, independently of central reflex pathways. 5-HT has been shown to facilitate ganglionic transmission (Wallis & Woodward, 1975; Round & Wallis, 1986) and has been demonstrated in isolated tracheal smooth muscle preparations to induce the release of acetylcholine by interacting with presynaptic neuronal receptors (Aas, 1983) .
In vitro results suggest that in the guinea-pig, 5-HT-induced bronchoconstriction could indeed result from parasympathetic system activation in the airways. Thus, in an innervated preparation of guinea-pig trachea, McCaig (1986) reported that atropine partially blocked the increase in intraluminal pressure induced by 5-HT. In guinea-pig tracheal strips, Baumgartner et al. (1990) showed that atropine significantly reduced the contractile response to 5-HT. In guinea-pig isolated perfused lungs, Bhattacharya (1955) demonstrated that atropine prevented 5-HT-induced bronchoconstriction. However, the existence of local parasympathetic activation within the 1 Author for correspondence at: Service de Pharmacologie Clinique, H6pital Henri Mondor, 94010 Creteil, France. airways in the bronchoconstriction induced by 5-HT in vivo has not been established.
The aims of our study were therefore: (1) to determine whether the bronchoconstrictor response to 5-HT in the guinea-pig is in part attributable to parasympathetic activation within the airways and (2) to characterize the subtype of 5-HT receptors involved in the interaction between the parasympathetic system and 5-HT, using selective 5-HT receptor agonists and antagonists.
Methods

Animals and general procedures
All experiments were performed on male Hartley strain guinea-pigs weighing 250-300g (Charles River, France), housed in a temperature-controlled room (21°C) with food and water freely available. Guinea-pigs were anaesthetized i.p. with 40mgkg-' pentobarbitone sodium. A repeat dose of 10mg kg 1 was given i.p. every 45 min throughout the experiments. These doses were selected so that the animals were surgically anaesthetized during the experiments. The trachea was cannulated, and polyethylene catheters were placed in the external jugular veins for drug administration and in the left common carotid artery for monitoring of blood pressure and heart rate via an indwelling cannula connected to a pressure transducer (Gould). The animals were mechanically ventilated and were paralysed by i.v. injection of 0.1 mgkg-' vecuronium bromide repeated every 30min throughout the experiments. Respiratory frequency was set at 60cyclesmin-m and tidal volume at 6mlkg-. Body temperature was kept constant at 380C by placing the animals on a thermostatically controlled heated blanket (Animal Blanket Unit, Harvard) to avoid nonspecific changes in bronchial reactivity (MacquinMavier et al., 1989) . Before the experiments began, the guineapigs were allowed 20 min to recover from the preparation procedure.
Measurement of respiratory mechanics
Airway responses to 5-HT were assessed by measuring respiratory system conductance and compliance. Both parameters were monitored continuously and determined on line from the total respiratory pressure, inspiratory flow and tidal volume signals, as described previously (Lorino et al., 1988 
Experimental protocol
The following procedure was used for all series of experiments: after the 20min stabilization period, the guinea-pigs were injected i.v. with a bolus of 1 mg kg-propranolol to minimize potential changes in bronchoconstrictor responses resulting from changes in levels of circulating catecholamines. Ten minutes later, they were given three sequential 5-HT challenges with increasing doses of 5-HT (40, 60 and 80ngkg-1s-1 respectively) at 15min intervals. During each challenge, 5-HT was infused i.v. for 5min until a plateau response was reached. Ten minutes elapsed between each challenge to allow respiratory parameters to return to within 5% of baseline values.
Three studies were performed. In the first, we explored the bronchoconstrictor responses to i.v. administered 5-HT, to see if they included a central vagal reflex and/or a significant peripheral cholinergic component. We reasoned that, if the local effects of 5-HT on cholinergic nerves in the airways were important in the mediation of 5-HT-induced bronchoconstriction, then in vagotomized guinea-pigs, treatment with atropine should reduce the airway responses to 5-HT. Accordingly, three groups of eight guinea-pigs each were pretreated i.v. with saline, bilateral cervical vagotomy or vagotomy plus 3mgkg-1 atropine respectively, 10min before 5-HT was injected and the dose-response curve recorded.
In the second study, we attempted to establish whether the peripheral cholinergic component of the airway responses to 5-HT may represent a stimulatory action of 5-HT on the efferent parasympathetic ganglia and/or at a site distal to the ganglia. For this purpose, we evaluated the airway responses to 5-HT in two groups of seven vagotomized guinea-pigs each, treated i.v. with either 2mgkg-' of the ganglion blocking agent hexamethonium or 2 mg kg-' hexamethonium plus 3mgkg-1 atropine 10min before 5-HT injection and doseresponse curve recording.
In the third study, we aimed to characterize the subtype of 5-HT receptors involved in the interaction between 5-HT and the peripheral cholinergic system. We evaluated the airway responses to 5-HT in four groups of vagotomized guinea-pigs treated i.v. with saline (n = 6), the 5-HT3 antagonist ICS (1 mgkg-1) (n = 6) or one of two doses of the 5-HT2 antagonist ketanserin (0.01 or 0.1 mgkg -) (n = 5 and 3 respectively) 10 min before 5-HT injection and dose-response curve recording. Since we found that ketanserin abolished 5-HT-induced bronchoconstriction, we studied two additional groups of six vagotomized guinea-pigs each, to confirm the involvement of 5-HT2 receptors in the peripheral cholinergic activation by 5-HT. These guinea-pigs were treated i.v. with saline or 3 mg kg'-atropine before two consecutive challenges with the 5-HT2 agonist, a-methyl-5-hydroxytryptamine maleate (a-methyl-5-HT), administered as 5min infusions at rates of 40 
Results
Effects of vagotomy and of vagotomy plus atropine on 5-hydroxytryptamine-induced bronchoconstriction 5-HT (40-80ngkg-'s-i) caused dose-related bronchoconstriction. As shown in Figure 1 , bilateral cervical vagotomy had no significant effect on 5-HT-induced bronchoconstriction. In contrast, this bronchoconstriction was significantly reduced when the vagotomized guinea-pigs were pretreated with atropine, whatever the degree of bronchoconstriction. Baseline respiratory conductance and compliance were not significantly different in guinea-pigs which underwent bilateral cervical vagotomy or vagotomy plus atropine compared to control levels (Table 1) guinea-pigs. Vagotomy did not affect the bronchoconstrictor response to 5-HT, whereas vagotomy plus atropine significantly reduced it, whatever the degree of bronchoconstriction. (** P < 0.01 versus controls). Effects of atropine on 5-hydroxytryptamine-induced bronchoconstriction in vagotomized guinea-pigs treated with hexamethonium
In vagotomized guinea-pigs pretreated with 2mg kg1 hexamethonium, bronchoconstrictor responses to 5-HT were significantly enhanced when 5-HT was infused at rates of 40 and 60 ng kg-1 s-(P < 0.05). As shown in Figure 2 , in vagotomized guinea-pigs pretreated with hexamethonium, atropine significantly reduced the bronchoconstrictor responses to 5-HT, whatever the degree of bronchoconstriction. 
Effects of
Discussion
In this study, we attempted to determine whether parasympathetic activation within the airways is involved in the bron- c . . choconstrictor responses to 5-HT in the guinea-pig. We conducted all our experiments in guinea-pigs pretreated with propranolol, and some of them in vagotomized guinea-pigs, to eliminate any possible modulation of airway contraction by activation of the sympathetic nervous system and/or the non adrenergic inhibitory system (Clerici et al., 1989) .
We found that atropine plus bilateral cervical vagotomy attenuated 5-HT-induced bronchoconstriction, whereas bilateral vagotomy alone had no effect. While vagotomy blocks only the central reflexes, atropine antagonizes the actions of acetylcholine resulting from either centrally or locally induced activation of the cholinergic system. While it is theoretically possible that atropine inhibits 5-HT-induced bronchoconstriction by a direct action at 5-HT receptors, there is no evidence that it exhibits such non-specific activity. Furthermore, Advenier et al. (1984) have previously shown that in guinea-pig trachea in vitro, atropine is of the order of 10,000 times more potent against acetylcholine than against 5-HT. Our results strongly suggest therefore that, in addition to exerting direct action on airway smooth muscle, 5-HT caused bronchoconstriction which was partly mediated by cholinergic activation within the airways, independently of central reflex pathways. In contrast to the results of previous studies in the dog and cat (Hahn et al., 1978; Parratt et al., 1982) demonstrating marked reduction of the bronchoconstrictor responses to 5-HT after bilateral vagotomy, we did not find a vagally mediated reflex component in the bronchoconstriction that 5-HT induced in the guinea pig. However, our findings do not rule out the possibility that reflex-mediated parasympathetic activation is involved in the bronchoconstrictor responses to 5-HT, since in the guinea-pig, vagotomy was earlier found, not only to suppress parasympathetic pathways but also to block reflex activation of the non adrenergic inhibitory system which modulates 5-HT-induced bronchoconstriction (Clerici et al., 1989) . In the dog and rabbit, parasympathetic activation within the airways was recently demonstrated to play a significant role in the airway responses to other bronchoconstrictor agents, e.g. histamine, platelet activating factor (PAF) and substance P (Shore et al., 1985; Leff et al., 1987; Grunstein et al., 1984) . As regards PAF and substance P, parasympathetic activation within the airways appears to be the sole contribution of the parasympathetic system to their bronchoconstrictor effects. Our results demonstrate that this mechanism also contributes to 5-HT-induced bronchoconstriction in the guinea-pig.
Because parasympathetic ganglia lie within the airway wall (Skoogh, 1988) , the parasympathetic nerve structures which might be activated within the airways by 5-HT after vagotomy include not only postganglionic pathways but also the parasympathetic ganglia. 5-HT has been shown to activate preganglionic parasympathetic nerve terminals in guinea-pig tracheal strips (Baumgartner et al., 1990) , and may also stimulate presynaptic receptors on cholinergic nerve terminals, as demonstrated in the isolated bronchial smooth muscle of the rat (Aas, 1983) . To determine the site of the peripheral cholinergic action of 5-HT, we compared the bronchoconstrictor responses to 5-HT by vagotomized guinea-pigs after ganglionic blockade with hexamethonium and after ganglionic plus muscarinic blockade with hexamethonium plus atropine. The observation that hexamethonium alone did not inhibit bronchoconstrictor responses to 5-HT, but that additional atropine treatment did cause a significant reduction suggests that the predominant site of the cholinergic action of 5-HT is located distal to the airway parasympathetic ganglia, i.e. on the parasympathetic nerve terminals. The additional observation that hexamethonium alone appeared actually to enhance 5-HT-induced responses was unexpected, and of uncertain significance.
To characterize the 5-HT receptor subtype involved in the interaction between 5-HT and the parasympathetic system, we studied the effects of the selective 5-HT3 antagonist, ICS 205-930 (Richardson et al., 1985) and of the selective 5-HT2 antagonist, ketanserin on the bronchoconstrictor responses to 5-HT in vagotomized guinea-pigs. The release of acetylcholine by 5-HT may result from the excitation of the 5-HT3 receptors on parasympathetic nerve terminals, as reported for rat bronchi and rabbit heart (Wallis, 1989) . However, in our experiments, ICS 205-930 did not reduce but rather enhanced 5-HT-induced bronchoconstriction. In contrast, ketanserin inhibited it. Similar inhibition by ketanserin of the bronchoconstrictor responses to the 5-HT was previously reported in guinea-pig isolated perfused lung by Selig et al. (1989) and in cats by Ball et al. (1983) . It is well established that the 5-HT receptors mediating tracheal smooth muscle contraction are of the 5-HT2 subtype (Cohen et al., 1985; Lemoine & Kauman, 1986) . Since there is no evidence that ketanserin interacts with muscarinic receptors (Awouters et al., 1982) , the most likely explanation for our results is that ketanserin prevented acetylcholine release. If true, this would suggest that the 5-HT receptors located on the parasympathetic nerve terminals are of the 5-HT2 subtype. To confirm such involvement of 5-HT2 receptors in the interaction between 5-HT and the parasympathetic system within the airways, we induced bronchoconstriction by infusing vagotomized guinea-pigs with the selective 5-HT2 agonist, a-methyl-5-HT (Richardson et al., 1985) , and found that atropine significantly reduced a-methyl-5-HT-induced bronchoconstriction.
In conclusion, our data suggest that the bronchoconstriction induced by infusion of 5-HT is elicited by two mechanisms: direct constriction of bronchial smooth muscle and indirect constriction of this muscle by postganglionic stimulation of the parasympathetic nerves. Both mechanisms are mediated by the stimulation of 5-HT2 receptors.
